IL6 and chronic obstructive pulmonary disease: Similar results were observed with regards to FCS-induced IL-6 (Fig. 1c), and CXCL8 release (Fig. 1d) with both being greatest in ASM from COPD subjects and having a lesser response to NaSH and GYY.